Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
Here's Why Investors Should Keep An Eye On Sundial Stock, Analyst's Thoughts Post Q1 Earnings
May 18, 2022
From Benzinga
This Cannabis Vape Market Leader Is Feeling Impact Of Price Competition, Analyst's Thoughts Post Q1 Earnings
May 17, 2022
Tickers
CBWTF
From Benzinga
From Benzinga
TerrAscend To See Top-Line & Margin Improvement In 2022, Analyst's Thoughts Post Q1 Earnings
May 13, 2022
Tickers
TRSSF
From Benzinga
From Benzinga
This Weedmaps Analyst Sees These 'Tailwinds' For Cannabis Tech Provider After Q1 Earnings
May 05, 2022
Tickers
MAPS
From Benzinga
Green Thumb Industries Analyst On Q1 Earnings: Cannabis Grower Has Enough Cash To Fuel Growth
May 05, 2022
Tickers
GTBIF
From Benzinga
This Cannabis MSO Is Well-Placed To Benefit From NJ Rec Market Launch, Analyst Thoughts Ahead Q1 Earnings
May 03, 2022
Tickers
GTBIF
From Benzinga
This Analyst Has Mixed Feelings About Tilray's Promise To Achieve $4B In Revenue By 2024, Here's Why
April 29, 2022
From Benzinga
Tilray Vs. Canopy Growth: Which Cannabis Stock Deserves Premium Valuation? Analyst Opines
April 28, 2022
From Benzinga
This Cannabis Retailer Is Poised To Grow Top-Line Despite Tough Environment, Analyst Explains Why
April 27, 2022
From Benzinga
From Benzinga
What To Focus On Now After Tilray's Q3 Earnings Report, Analyst Shares Main Takeaways
April 07, 2022
Tickers
TLRY
From Benzinga
Curaleaf Holdings To Report Q1 Results In Anticipation Of New Jersey Legal Cannabis Launch
April 06, 2022
Tickers
CURLF
From Benzinga
Jushi's Earnings Power Is Evolving But This Analyst Remains Sidelined, At Least For Now
March 29, 2022
Tickers
JUSHF
From Benzinga
Why Is Trulieve Still Among Top Cannabis Stock Picks? Analyst's Thoughts Ahead Of Q4 Earnings
March 29, 2022
From Benzinga
From Benzinga
Analyst on Charlotte's Web: 'We Stay Neutral, But Do Keep An Eye On This CBD Sector Bellwether Stock'
March 25, 2022
From Benzinga
When Will New Jersey's Recreational Marijuana Sales Begin? What's Next After Another Delay?
March 25, 2022
Tickers
CURLF
From Benzinga
From Benzinga
Pharmacist Managing Billion Dollar Cannabis-Focused Fund, Jason Wild Of TerrAscend: Meet Our Keynote Speakers
March 23, 2022
From Benzinga
From Benzinga
Analyst Is Warming Up To This Cannabis Stock As It Reports Q1 Earnings & Successful Shift To Discount Model
March 18, 2022
Tickers
HITI
From Benzinga
Why Federal Cannabis Legalization Is 'A Question Of When, Not If,' Says Canopy Growth CEO: Meet Our Keynote Speakers
March 15, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
